OS-3-106

CAS No. 1580000-17-4

OS-3-106( —— )

Catalog No. M23687 CAS No. 1580000-17-4

OS-3-106 is a novel arylamide phenylpiperazines, as partial agonists at the D3R in the adenylyl cyclase inhibition assay.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
10MG 29 In Stock
25MG 61 In Stock
50MG 104 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    OS-3-106
  • Note
    Research use only, not for human use.
  • Brief Description
    OS-3-106 is a novel arylamide phenylpiperazines, as partial agonists at the D3R in the adenylyl cyclase inhibition assay.
  • Description
    OS-3-106 is a novel arylamide phenylpiperazines, as partial agonists at the D3R in the adenylyl cyclase inhibition assay.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    D3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1580000-17-4
  • Formula Weight
    450.6
  • Molecular Formula
    C25H30N4O2S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    COC1=CC=CC=C1N2CCN(CC2)CCCCNC(=O)C3=CC=C(C=C3)C4=CSC=N4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Cheung T , Loriaux A L , Weber S M , et al. Reduction of cocaine self-administration and D3 receptor-mediated behavior by two novel dopamine D3 receptor-selective partial agonists, OS-3-106 and WW-III-55.[J]. Journal of Pharmacology & Experimental Therapeutics, 2015, 347(2):410-23.
molnova catalog
related products
  • JNJ-37822681

    JNJ-37822681 is a novel, highly selective dopamine D? receptor antagonist characterized by a rapid dissociation rate from the dopamine D? receptor.

  • Tavapadon

    Tavapadon (PF 6649751, PF-06649751) is an orally available dopamine D1 receptor partial agonist for treatment of Parkinson's disease.

  • Alizapride hydrochlo...

    Alizapride hydrochloride is a dopamine receptor antagonist used for the theropy of nausea and vomiting.